Influence of dexmedetomidine upon sevoflurane end-expiratory concentration. Evaluation by bispectral index, suppression rate and electroencephalographic power spectral analysis;Influência da dexmedetomidina na concentração expirada do sevoflurano. Avaliação pelo índice bispectral, taxa de supressão e Análise espectral da potência do eletroencefalograma

Revista Brasileira de Anestesiologia

Volumn 52, Issue 2, 2002, Pages 133-145

  Nunes, Rogean Rodrigues ^a,c   Cavalcante, Sara Lúcia ^a,b  

^a Hospital de Cirurgia e Anestesia   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c NONE   (Brazil)

Author keywords

Analgesics: dexmedetomidine; Anesthetics, Volatile: sevoflurane; Monitoring: electroence falography, bispectral index, SEF 95 , power spectral analysis

Indexed keywords

DEXMEDETOMIDINE; SEVOFLURANE; SODIUM CHLORIDE;

ADULT; ANESTHESIA INDUCTION; ANESTHESIA LEVEL; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; GENERAL ANESTHESIA; HEART RATE; HEMODYNAMICS; HUMAN; INTUBATION; LAPAROSCOPY; MINIMUM LUNG ALVEOLUS CONCENTRATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0036131329     PISSN: 00347094     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine
2. Ahpha-2-Adrenergic agents in anaesthesia
3. Anaesthesia: A practical or impractical construct?
4. A primer for EEG signal processing in anesthesia
5. Power spectral analysis of the electroencephalogram during increasing end-expiratory concentrations of isoflurane, desflurane and sevoflurane
6. Spectral edge frequency of the electroencephalogram to monitor "depth" of anaesthesia with isoflurane or propofol
7. Effects of intravenous dexmedetomidine in humans, II: Hemodynamic changes
8. Effects of dexmedetomidine, a selective alpha 2-adrenoceptor agonist, on hemodynamic control mechanisms
9. Good clinical research practice (GCRP) in pharmacodinamyc studies of neuromuscular blocking agents
10. 2 saturation during carotid endarterectomy
11. A comparison of spectral edge, delta power, and bispectral index as EEG measures of alfentanil, propofol, and midazolam drug effect
12. Dexmedetomidine
13. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions
14. Dexmedetomidine injection into the locus ceruleus produces antinociception
15. Intravenous or epidural clonidine for intra-and postoperative analgesia
16. Pretreatment with dexmedetomidine: Altered indices of anesthetic depth for halothane in the neuraxis of cats
17. Inhibition of adenylate cyclase in the locus ceruleus mediates the hypnotic response to alpha-2-agonist in the rat
18. Perturbation of ion conductance in the locus ceruleus alters the hypnotic response to the alpha-2-adrenergic agonist dexmedetomidine in the locus ceruleus in rats
19. Clinical uses of alpha-2-adrenergic agonists
20. Substitution of a mutant alpha2A-adrenergic receptor via "hit and run" gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo
21. The mechanism of alpha-2-adrenergic inhibition of sympathetic ganglionic transmission
22. [Alpha]-2-adrenoceptor agonists in anaesthesia: A new paradigm
23. Cardiovascular regulation in mice lacking alpha-2-adrenergic receptor subtypes b and c
24. The effects of increasing plasma concentrations of dexmedetomidine in humans
25. Alpha-2 - And imidazoline receptor agonists: Their pharmacology and therapeutic role
26. Ventilatory affects of premedication with clonidine
27. The effects of intravenous clonidine on ventilation
28. Ventilatory response to carbon dioxide after epidural clonidine injection
29. Ventilatory, hemodynamic and sedative effects of the alpha 2 adrenergic agonist, dexmedetomidine
30. Effects of intravenous dexmedetomidine in humans
31. Dexmedetomidine, an alpha-2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing gynecologic surgery
32. Intramuscular dexmedetomidine as premedication for general anesthesia
33. A comparison of IM dexmedetomidine and midazolam premedication for elective abdominal hysterectomy
34. Effects of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation
35. Antinociceptive interaction between opioids and dexmedetomidine: Systemic addtivity and spinal synergy
36. Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy
37. Effects of ablation of serotonin or norepinephine brain stem areas on halothane and cyclopropane MACs in rats
38. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha-2-adrenergic receptor
39. Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics
40. The effects of dexmedetomidine in patients in the intensive care setting
41. Dexmedetomidine efficacy for ICU postoperative sedation
42. Effect of dexmedetomidine on the minimum alveolar concentration (MAC) of sevoflurane in adults age 55 to 70 years
43. The effect of dexmedetomidine on EEG-bispectral index